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Available online 1 September 2018Background: Characteristics and risk factors associated with electrocardiographic borderline Q-waves are not
fully elucidated, especially in individualswithout overt cardiovascular disease (CVD). Also, the relation of isolated
and non-isolated borderline Q-waves with subclinical atherosclerosis and vascular stiffness is unknown.
Methods and results:We included 5746 Netherlands Epidemiology of Obesity study participants without overt
CVD. Participants were divided in three groups: no Q-waves (93.7%), isolated (4.6%) and non-isolated borderline
Q-waves (1.7%). Borderline Q-waves were defined as Minnesota Codes 1.2.x and 1.3.x and non-isolated as ≥1 of
abnormal QRS axis, left ventricular hypertrophy or ST/T abnormalities. Several characteristics and measures of
body fat were assessed. Vascular stiffness was assessed by pulsewave velocity (PWV) and subclinical atheroscle-
rosis by carotid intima-media thickness (cIMT). Percentage of men, alcohol intake, blood pressure and fasting
glucose concentrations were, compared with no Q-waves, higher in the isolated and highest in the non-
isolated borderline Q-wave group. Isolated borderline Q-waves were associated with higher body mass index
(difference compared with no Q-waves: 1.0 kg/m2; 95%CI: 0.3–1.7; p-value: 0.006), waist circumference (3.4 cm;
1.0–5.8; 0.005), and visceral adipose tissue (21.9 cm2; 7.4–36.3; 0.003) and differences were even larger for non-
isolated borderline Q-waves. Compared with no Q-waves, non-isolated borderline Q-waves were associated with
higher PWV (1.2 m/s; 0.4–2.0; 0.004) and cIMT (23.4 μm; 3.0–43.8; 0.024), whereas isolated borderline Q-waves
were not.
Conclusion: Cardiovascular risk factors and measures of body fat, especially abdominal adiposity, were higher in
participants with isolated borderline Q-waves, comparedwith no Q-waves, and highest in the non-isolated border-
line Q-wave group. Non-isolated borderline Q-waves were associated with subclinical atherosclerosis and vascular
stiffness. Future studies should investigate potential added value of borderline Q-waves in CVD prediction.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Subclinical atherosclerosis
Vascular stiffness1. Introduction
The electrocardiogram (ECG) is commonly used in medical practice
to assess the electrical activity in the heart, and abnormalities seen on an
individual's ECG can have clinically relevant prognostic or diagnostic
value for cardiovascular diseases (CVD) [1,2]. Large Q-waves on an
ECG can be seen after a myocardial infarction, but can also be seen inl Center, PO Box 9600, 2300RC
eliability and freedom from bias
. This is an open access article underapparently ‘healthy’ individuals, in whom they are thought to reflect
silent ischemia [3]. Next to large Q-waves, smaller abnormalities, such
as borderline Q-waves can also be found on the ECG of an individual
with or without established cardiovascular disease (CVD), and may be
associated with subclinical cardiovascular pathology. Without other
ECG abnormalities present, these borderline Q-waves are considered
isolated. However they can also be non-isolated, i.e. co-existing with
other ECG abnormalities. Clinical characteristics and risk factor profiles
of individuals with these borderline Q-waves are not fully elucidated,
especially not in individuals without known CVD. In large cohort stud-
ies, it was observed that individuals with borderline Q-waves tended
to be older, more often suffering from diabetes mellitus and hyperten-
sion and also seemed to have a worse kidney function than individualsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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vorable metabolic profile, associations with body mass index (BMI)
were not demonstrated [4,6]. Although previous studies did not observe
an association between BMI and borderline Q-waves, other measures of
body fat distribution, notably metabolically active visceral fat, might be
associated with borderline Q-waves [7]. It is well-established that in
particular abdominal adiposity is associated with CVD and mortality
[7–9]. This association with abdominal adiposity could also be present
for borderline Q-waves.
Furthermore, the clinical relevance of a borderline Q-wave, espe-
cially an isolated borderlineQ-wave, in an individualwithout previously
knownCVD is not clear. The literature is inconclusive on the importance
of borderline, and especially isolated borderline Q-waves in individuals
free of established CVD, with some studies reporting increased cardio-
vascular risk in individuals with borderlineQ-waves [4], some reporting
no increased cardiovascular risk [5] and some studies reporting
increased cardiovascular risk for non-isolated borderline Q-waves only
[6].
Consequently, the present study was conducted with two aims.
Firstly, we aimed to investigate clinical characteristics and measures of
body fat distribution in individuals without Q-waves, with isolated bor-
derline Q-waves and with non-isolated borderline Q-waves. Secondly,
we aimed to investigatemeasures of subclinical atherosclerosis and vas-
cular stiffness in individuals with isolated and non-isolated borderline
Q-waves compared with individuals without Q-waves.
2. Methods
2.1. Study design and population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based,
prospective cohort study designed to investigate pathways that lead to obesity-related
diseases, in which 6671 individuals were enrolled between 2008 and 2012. Men and
women aged between 45 and 65 years with a self-reported BMI of 27 kg/m2 or higher
living in the area of greater Leiden (in the Netherlands) were eligible to participate in
the NEO study. In addition, all inhabitants aged between 45 and 65 years from onemunic-
ipality (Leiderdorp) were invited to join irrespective of their BMI, allowing for a reference
distribution of BMI. Individuals were invited to a baseline visit at the NEO study center of
the Leiden University Medical Center after an overnight fast. At the time of inclusion,
individuals completed a screening form, which enquired about anything that might create
a health risk or thatmight interferewith imaging (most notablymetallic devices, claustro-
phobia, or a body circumference of N1.70 m). Of the participants without contra-
indications for MRI, approximately 35% were randomly selected to undergo MRI. Prior to
the study visit, participants completed a questionnaire at home with demographic, life-
style, and clinical information. At the study center all participants underwent an extensive
physical examination, including anthropometry, blood sampling, and an ECG. The present
analysis is a cross-sectional analysis using the baseline measurements of the NEO study.
Participants using QT-prolonging drugs, participants with a history of myocardial infarc-
tion or angina pectoris and participants with an artificial pacemaker were excluded
from the study population. Furthermore, participants with large Q-waves were excluded
from the present study, because we were particularly interested in the clinical relevance
of borderline Q-waves. Further details of the study design and population have been
described in detail elsewhere [10]. TheMedical Ethics Committee of the Leiden University
Medical Center approved the design of the study and all participants gave their written
informed consent.
2.2. Data collection
The ethnicity of participants was self-identified in eight categories on the question-
naire and then grouped into white (N95%) and other. Level of education was reported in
10 categories according to the Dutch education system and grouped as low or high
education. Tobacco smoking was categorized into current smoker, former smoker, or
never smoker. Alcohol consumption was reported using a food frequency questionnaire
and calculated into grams/day [11]. Participants reported the frequency and duration of
their physical activity in leisure timewhichwas expressed in hours per week ofmetabolic
equivalents (MET-h/week) using the Short Questionnaire to Assess Health-enhancing
physical activity [12]. Participants were asked to bring all the medication they were cur-
rently using to the study visit. Brachial blood pressure was measured in a seated position
on the right armusing a validated automatic oscillometric device (OMRON,ModelM10-IT,
Omron Health Care Inc., IL, USA). Blood pressure was measured three times with 5 min
rest between consecutive measurements. The mean systolic and diastolic blood pressure
were calculated. Blood samples were drawn after an overnight fast of 10 h. Fasting
glucose, triglyceride and high-density lipoprotein concentrations as well as creatinine
concentration were measured with standard methods in the central clinical chemistrylaboratory of the Leiden University Medical Center [10]. Glomerular filtration rate was
estimated by using the CKD-EPI formula [13].
2.3. Electrocardiography
Q-waves were assessed using the Minnesota Coding System, a system to objectively
describe electrocardiographic findings [14]. This systemdivides Qwaves into three groups
based onMinnesota Codes (MC); group 1 codes: 1.1.1 to 1.1.7, group 2 codes: 1.2.1 to 1.2.8
and group 3 codes: 1.3.1 to 1.3.8. In addition, the codes are applied to three groupings of
leads namely, I, aVL, V6 (anterolateral), II, III, aVF (inferior) and V1-V5 (anterior). Not
every code is present in every group of leads, e.g. 1-2-4 in the inferior leads is not present
in the anterior leads and no codes are based on the waveforms in the aVR lead. Examples
of different Q-waves (no abnormal Q-wave, borderline Q-wave and large Q-wave) are
shown in Supplementary Fig. 1. In this study, borderline Q-waves were defined as group
2 and group 3 codes and large Q-waves as group 1 codes. Abnormal QRS axis was defined
as QRS axis b−30° or QRS axis N+90°, minor ST/T abnormalities as MC 4.3, 4.4, 5.3 of 5.4,
major ST/T abnormalities as MC 4.1, 4.2, 5.1 or 5.2 and left ventricular hypertrophy as MC
3.1 or 3.2. Percentages of ECG abnormalities in participants without Q-waves and with
borderline Q-waves were calculated and the study population was divided in the three
groups, namely participants without Q-waves, participants with isolated borderline
Q-waves and participants with non-isolated borderline Q-waves. Isolated borderline
Q-wavesweredefined as borderlineQ-wavewith normalQRS axis, nominor ST/T abnormal-
ity, no major ST/T abnormality and no left ventricular hypertrophy and non-isolated bor-
derline Q-waves were defined as borderline Q-waves plus at least one of these additional
abnormalities.
2.4. Measures of body fat
Height and weight were measured without shoes and 1 kg was subtracted from the
weight to correct for clothing. BMI was calculated by dividing the weight in kilograms
by the height in meters squared. Waist circumference was measured with a horizontally
placed flexible tape in the middle of the distance between the lowest rib and the iliac
crest. Hip circumference was measured at the maximum circumference of the buttocks.
Waist-hip-ratio (WHR) was calculated by dividing thewaist circumference by the hip cir-
cumference. With a bio-impedance device (TBF-310, Tanita International Division, UK)
total body fat (TBF) was estimated. Abdominal subcutaneous adipose tissue (aSAT) and
visceral adipose tissue (VAT)were assessed byMR imaging (1.5 TeslaMR imaging, Philips
Medical Systems) using a turbo spin echo imaging protocol. Three transverse imageswith
a slice thickness of 10mmwere obtained at the level of the fifth lumbar vertebra during a
breath-hold. The fat depots were converted from the number of pixels to centimeters
squared. In the analyses, the average of the three slices was used.
2.5. Measures of subclinical atherosclerosis and vascular stiffness
Carotid intima-media thickness (cIMT) was assessed by ultrasonography of the far
wall of the left and right common carotid arteries along a 15 mm long section 10 mm
proximal of the bifurcation in recumbent position. A 7.5–10 MHz linear-array transducer
(Art.Lab version 2.1, Esaote, Maastricht, The Netherlands) in B-mode setting was used to
visualize the distal common carotid arteries and a wall track system was used to detect
the lumen-intima and media-adventitia boundaries. The cIMT was measured in three
predefined angles per side (180, 135 and 90° for the right common carotid artery and
180, 225 and 270° for the left common carotid artery) during six heartbeats. Mean cIMT
was calculated for each individual by averaging all 36 cIMT measurements within each
individual. Velocity-encoded magnetic resonance imaging was used for assessment of
pulse wave velocity (PWV) of the aorta. The heart was imaged in short-axis view using
an ECG-triggered balanced turbo-field-echo sequence. Data were analyzed using
in-house software (MASS and FLOW; Leiden University Medical Center, Leiden, the
Netherlands).
2.6. Statistical analysis
In theNEO study, participants with a BMI of 27 kg/m2 or higherwere oversampled. To
correctly represent baseline associations in the general population [15] adjustments for
the oversampling of individuals with a BMI 27 kg/m2 were made. This was done by
weighting all participants towards the BMI distribution of participants from the
Leiderdorp municipality [16], whose BMI distribution was similar to the BMI distribution
of the general Dutch population [17]. All results are based on weighted analysis. Conse-
quently, the results are considered to apply to a population-based study without
oversampling of participants with a BMI ≥ 27 kg/m2.
Baseline characteristics are presented as mean (SD), median (25th, 75th percentiles)
or as percentage, for the three specified groups. Next, means (se) of measures of body fat
were calculated for each group. Differenceswith 95% confidence intervals were estimated
for the groupswith Q-waves compared to the groupwithout Q-waves using linear regres-
sion analysis. If differences in BMI, TBF or aSATwere observed between groups, thesewere
adjusted for VAT and if differences in waist circumference or VAT were observed, these
were adjusted for TBF. Finally, subclinical atherosclerosis and vascular stiffness were in-
vestigated in the three groups and again, differences with 95% confidence intervals were
estimated compared with the group without Q-waves. No adjustment for confounding
was made since our two study aims were mostly of a descriptive nature. Data were
analyzed using STATA (Statacorp, College Station, Texas, USA), version 14.
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3.1. Study groups
681 participants using QT-prolonging drugs were excluded.
Similarly, 129 participants with a history of myocardial infarction, 61
with angina pectoris and 6 participants with an artificial pacemaker
were excluded. Also, 48 participants with large Q-waves (MC 1.1.x)
were excluded. The total number of participants included in this study
was 5746, of which 43% were men. Participants were then divided in
participants without Q-waves, with isolated borderline Q-waves and
with non-isolated borderline Q-waves. Percentages of other ECG abnor-
malities in participants without and with borderline Q-waves are
shown in Fig. 1. Other ECG abnormalities were more prevalent among
participants with borderline compared with no Q-waves. In 16% of
participantswithout Q-waves and in 27%of participantswith borderline
Q-waves, at least one of the other ECG abnormalities was present. Of the
studypopulation, 93.7% did not haveQ-waves, 4.6%had isolated border-
line Q-waves and 1.7% had non-isolated borderline Q-waves.
3.2. Baseline characteristics
Baseline characteristics of the three groups (no Q-waves, isolated
borderline Q-waves and non-isolated borderline Q-waves) are pre-
sented in Table 1. Several risk factors were, compared with participants
without Q-waves, higher in participants with isolated borderline
Q-waves and highest in participants with non-isolated borderline,
namely age (55.6, 55.7 and 59.0 years respectively), percentage of
men (43, 52 and 61% respectively), systolic (129.9, 131.1 and
137.5 mmHg respectively) as well as diastolic blood pressure (83.1,
83.1 and 86.9 mmHg respectively), use of antihypertensive therapy
(20, 23 and 32% respectively), fasting glucose (5.4, 5.6 and 5.7 mmol/l
respectively), triglycerides (1.0, 1.0 and 1.2 mmol/l respectively) and
use of lipid lowering therapy (8, 13 and 14% respectively). Furthermore,
participants with non-isolated borderline Q-waves were less often
highly educated (47, 51 and 36% respectively) and had the highest alco-
hol intake out of the three groups (9.9, 8.8 and 19.2 g/day respectively).
No relevant differences were observed in triglyceride, LDL-cholesterol
or HDL-cholesterol concentrations or estimated glomerular filtration
rate between the groups.
3.3. Borderline Q-waves and measures of body fat
Table 2 reports measures of body fat in the three groups. For mea-
sures of body fat, participants with isolated borderline Q-waves had a
higher BMI (difference: 1.0 kg/m2; 95% confidence interval: 0.3–1.7;
p-value: 0.006), higher waist circumference (3.4 cm; 1.0–5.8; 0.005),Fig. 1. ECG abnormalities in participants without and with borderline Q-waves. Data are
presented as percentages and 95% confidence intervals. Results are based on analyses
weighted towards the body mass index distribution of the general population (n = 5746).
Abnormal QRS axis: b−30/N+90; LVH: MC 3.1, 3.2; minor ST/T abnormality: MC 4.3, 4.4,
5.3, 5.4; major ST/T abnormality: MC 4.1, 4.2, 5.1, 5.2.and more VAT (21.9 cm2; 7.4–36.3; 0.003) compared with participants
withoutQ-waves. The difference ofmeasures of body fat for participants
with non-isolated borderline Q-waves compared with participants
without Q-waves was even larger (BMI: 1.7 kg/m2; 0.7–2.8; 0.001;
waist circumference: 5.5 cm; 2.2–8.8; 0.001; VAT: 29.3; 7.8–50.7;
0.007; WHR: 0.03; 0.01–0.05; 0.001). There were no differences be-
tween participants with isolated or non-isolated borderline Q-waves
and participants without Q-waves for TBF and aSAT. Furthermore,
the difference in BMI between groups disappeared after adjusting
for VAT (isolated borderline Q-waves compared with no Q-waves:
−0.2 kg/m2; −0.9–0.6; 0.620 and non-isolated borderline Q-waves
compared with no Q-waves: 1.1 kg/m2; −0.3–2.4; 0.134), while the
difference in waist circumference and VAT between groups remained
after adjusting for TBF.
3.4. Borderline Q-waves and subclinical atherosclerosis and vascular
stiffness
In Table 3 measures of subclinical atherosclerosis and vascular
stiffness are shown in the three groups. The differences between
participants with isolated borderline Q-waves and participants without
Q-waves were small for both PWV (−0.2 m/s;−0.5–0.1; 0.139) as for
cIMT (2.7 μm; −11.2–16.5; 0.704). However, participants with non-
isolated borderline Q-waves had a higher PWV (difference: 1.2 m/s;
95%CI: 0.4–2.0; 0.004) as well as higher cIMT (23.4 μm; 3.0–43.8;
0.024) compared with participants without Q-waves.
4. Discussion
In this cross-sectional analysis of 5746 participants of theNEO study,
we observed, compared with participants without Q-waves, a worse
cardiovascular risk profile in participants with isolated borderline
Q-waves, that was even worse in participants with non-isolated
borderline Q-waves. Participants with non-isolated borderline
Q-waves, compared with participants without Q-waves were older,
more oftenmale, had a higher alcohol intake and also higher blood pres-
sure and fasting glucose concentrations. For participants with isolated
borderline Q-waves, compared with participants without Q-waves,
cardiovascular risk factors were more often present, however, less
evident than for participants with non-isolated borderline Q-waves.
This association between cardiovascular risk factors and borderline
Q-waves is in line with literature, although reports vary in the exact
risk factors associated with borderline Q-waves [4–6]. Borderline
Q-waves could be the result of scar tissue, in which no electrical activity
is present, representing damage to the heart tissue.
We observed higher values of several measures of body fat (BMI,
waist circumference, VAT and WHR) in participants with isolated
borderline Q-waves and the highest values in participants with non-
isolated borderline Q-waves, compared with participants without
Q-waves. No differences were observed for TBF or aSAT. Two previous
studies report no differences in BMI between individuals with border-
line Q-waves and without [4,6]. In the general population-based 4th
Copenhagen City Heart Study mean BMI in 5267 individuals without
Q-waves was 25.7 kg/m2, whereas this was 26.3 kg/m2 in 114 individ-
uals with Q-waves (defined asMC 1.1.X to 1.3.X) [4]. Despite this differ-
ence not being statistically significant, similar to our study, individuals
with Q-waves have a higher BMI than individuals without Q-waves.
Furthermore, a study in the general Japanese population did not observe
differences in BMI between individuals without abnormal Q-waves
(men: 22.5 kg/m2, women: 22.8 kg/m2), individuals withmild abnormal
Q-waves (defined as MC 1-3-X; men: 22.9 kg/m2, women: 23.0 kg/m2)
and individuals with moderate/severe abnormal Q-waves (defined as
MC 1-2-X or 1-1-X; men: 22.1 kg/m2, women: 24.4 kg/m2) [6]. In this
Japanese population the BMI of individuals is generally lower than the
BMI of Dutch individuals included in the NEO study, which makes it
difficult to compare these results to our study. Our results are plausible,
Table 1
Characteristics of 5746 participants aged 45 to 65 years from the Netherlands Epidemiology of Obesity study.
No Q-waves, 93.7% Isolated borderline Q-waves, 4.6% Non-isolated borderline Q-waves, 1.7%
Age, years 55.6 (6.0) 55.7 (6.6) 59.0 (6.5)
Sex, men, % 43 52 61
Ethnicity, white, % 95 99 99
Education level, high, % 47 51 36
Alcohol intake, g/day 9.9 (2.9–21.1) 8.8 (3.2–20.8) 19.2 (7.7–25.0)
Physical activity (MET-hour/week) 30.0 (16.0–50.5) 26.9 (14.0–45.5) 29.0 (17.8–52.0)
Smoking, %
Never 39 39 22
Former 45 44 68
Current 16 16 10
Body mass index, kg/m2 25.6 (23.1–28.1) 26.7 (23.7–29.0) 27.4 (24.9–29.9)
Systolic blood pressure, mmHg 129.9 (16.9) 131.1 (18.5) 137.5 (20.3)
Diastolic blood pressure, mmHg 83.1 (10.2) 83.1 (11.6) 86.9 (11.4)
Use of antihypertensive therapy, % 20 23 32
Fasting plasma glucose, mmol/l 5.4 (0.9) 5.6 (1.2) 5.7 (1.3)
Diabetes mellitus, % 5 10 7
Triglycerides, mmol/l 1.0 (0.7–1.4) 1.0 (0.7–1.7) 1.2 (0.7–1.8)
LDL, mmol/l 3.6 (0.9) 3.5 (1.1) 3.6 (1.2)
HDL, mmol/l 1.6 (0.5) 1.5 (0.5) 1.5 (0.6)
Use of lipid lowering therapy, % 8 13 14
eGFR, ml/min/1.73m2 86.3 (12.3) 86.6 (12.5) 84.9 (13.5)
eGFR, estimated glomerular filtration rate (CKD-EPI); HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein; MET, metabolic equivalent of task during leisure time.
Data are presented as mean(SD), median(25th, 75th percentiles), or percentages.
Results were based on analyses weighted towards the BMI distribution of the general population.
Borderline Q-wave: Minnesota codes 1.2.X, 1.3.X.
No Q-waves, n = 5294; isolated borderline Q-waves, n = 317; non-isolated borderline Q-waves, n = 135.
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both waist circumference and VAT are measures of abdominal adiposity
and no differences were observed for TBF between groups, we also
investigated whether differences in BMI between groups were mainly
due to differences in abdominal adiposity. Indeed, the difference in BMI
between groups disappeared after adjustment for waist circumference
or VAT, indicating that differences in abdominal adiposity between the
three groups are also responsible for the observed BMI difference.
Finally, we observed that PWV and cIMT, measures of subclinical
atherosclerosis and vascular stiffness, were higher in participants
with non-isolated borderline Q-waves than in participants without
Q-waves, but that this was less clear for isolated borderline Q-waves.
This association of non-isolated borderline Q-waves with more subclin-
ical atherosclerosis and vascular stiffness is in line with the increased
prevalence of cardiovascular risk factors, the presence of other ECG
abnormalities, and more abdominal adiposity.
The fact that borderline Q-waves are associated with specifically
higher amounts of VAT gives more insight into the cardiovascular risk
associatedwith these borderline Q-waves. Several underlying pathways
are thought to be involved in these associations. Visceral adipocytes
have high lipolytic activity and cause an increased amount of free fatty
acids to be released into the portal circulation, leading to hepatic insulin
resistance and adverse cardiovascular effects [18–20]. Furthermore, VAT
is a metabolically active tissue, secreting several cytokines, chemokinesTable 2
Relations between borderline Q-waves and measures of body fat.
No Q-waves [1],
93.7%
Isolated borderline Q-waves
[2], 4.6%
Non-isolated borde
[3], 1.7%
BMI, kg/m2 26.1 (0.1) 27.1 (0.4) 27.8 (0.5)
TBF, % 31.5 (0.2) 31.6 (0.7) 31.3 (1.2)
aSAT, cm2 232.0 (2.5) 238.9 (12.8) 254.0 (21.8)
Waist circ., cm 91.4 (0.2) 94.8 (1.2) 96.9 (1.7)
VAT, cm2 86.6 (1.5) 108.5 (7.2) 115.9 (10.8)
WHR 0.88 (0.00) 0.90 (0.01) 0.92 (0.01)
aSAT, abdominal subcutaneous adipose tissue; BMI, Body Mass Index; TBF, total body fat; VAT
Data are presented asmean (se) and difference (95% confidence interval). Results are based on l
For VAT and aSAT: no Q-waves n = 2099; isolated borderline Q-waves n = 121; non-isolated
* 2 vs 1, ** 3vs 1.and hormones, and has been linked to several unfavorable conditions,
such as insulin resistance, impaired lipid and glucose metabolism, CVD
andmortality [21–24]. More VAT is also accompanied by higher concen-
trations of pro-inflammatory factors, such as interleukin 6, tumor
necrosis factor-α and C-reactive protein, that can enhance a local
pro-inflammatory environment, but also can havemore systemic effects,
promoting atherosclerotic disease and arterial stiffness [7,25–30].
Also, associations between VAT and more subclinical atherosclerosis
and vascular stiffness have been shown in the literature and abdominal
adiposity has been described as a stronger risk factor for subclinical
atherosclerosis and vascular stiffness than overall adiposity [31–33].
In current practice, borderline isolatedQ-waves are often considered
as non-pathological. However, the appearance of a borderline isolated
Q-wave on the ECG of an individual without known CVD could
represent electrical damage, an unrecognized myocardial infarction,
and be associated with a worse prognosis [34]. Especially the presence
of a 1.2 coded borderline Q-wave together with T wave changes, could
be the result of an unrecognized myocardial infarction, which was
associated with poor prognosis previously [35,36]. The borderline
Q-wave could also just be a positional variant, without any prognostic
consequences, which makes clinical decision making particularly
complicated. Borderline Q-waves could possibly improve current risk
prediction scores for CVD. In 6991 individuals from the Copenhagen
Heart Study aged 65 years and over, ECG changes among whichrline Q-waves Difference 2 vs
1 (95%CI)
p-value* Difference 3 vs
1 (95%CI)
p-value**
1.0 (0.3–1.7) 0.006 1.7 (0.7–2.8) 0.001
0.2 (−1.3–1.6) 0.828 −0.2 (−2.6–2.1) 0.855
7.0 (−18.5–32.5) 0.593 22.1 (−21.0–65.1) 0.315
3.4 (1.0–5.8) 0.005 5.5 (2.2–8.8) 0.001
21.9 (7.4–36.3) 0.003 29.3 (7.8–50.7) 0.007
0.01 (−0.00–0.03) 0.098 0.03 (0.01–0.05) 0.001
, visceral adipose tissue; Waist circ., waist circumference; WHR, waist:hip ratio.
inear regression analysesweighted towards the BMI distribution of the general population.
borderline Q-waves n = 50.
Table 3
Relations between borderline Q-waves and subclinical atherosclerosis and vascular stiffness.
No Q-waves [1],
93.7%
Isolated borderline Q-waves [2],
4.6%
Non-isolated borderline Q-waves [3],
1.7%
Difference 2 vs 1 (95%CI) p-value * Difference 3 vs 1 (95%CI) p-value **
PWV, m/s 6.6 (0.0) 6.3 (0.1) 7.8 (0.4) −0.2 (−0.5–0.1) 0.139 1.2 (0.4–2.0) 0.004
cIMT, μm 614.7 (1.9) 617.4 (6.8) 638.1 (10.2) 2.7 (−11.2–16.5) 0.704 23.4 (3.0–43.8) 0.024
cIMT, carotid intima media thickness; PWV, pulse wave velocity.
Data are presented as mean (se) or difference (95% confidence interval) Results are based on linear regression analyses weighted towards the BMI distribution of the general population.
For PWV: no Q-waves n = 2032; borderline isolated Q-waves n = 119; non-isolated borderline Q-waves n = 45.
For cIMT: no Q-waves n = 5233; borderline isolated Q-waves n = 313; non-isolated borderline Q-waves n = 135.
* 2 vs 1, ** 3vs 1.
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non-fatal cardiovascular events [37]. Future studies should further
elucidate the role of borderline Q-waves in cardiovascular risk prediction.
In this studyweobserved aworse cardiovascular risk factor profile aswell
as higher waist circumference and VAT in participants with isolated
borderline Q-waves, which was even more pronounced in participants
with non-isolated borderline Q-waves, compared with participants
withoutQ-waves.Wealso observednon-isolated, but not isolatedborder-
line Q-waves to be associated with more subclinical atherosclerosis and
vascular stiffness, compared with no Q-waves. Therefore it would be of
great interest to investigate the association of borderline Q-waves with
cardiovascular riskwithin certain subgroups of individualswith increased
cardiometabolic risk. Future studies should be investigated whether it
might be indicated to further investigate borderline Q-waves when
found on an individuals' ECG, especially in individuals with increased
waist circumference or VAT,who already are at higher cardiovascular risk.
4.1. Strengths and limitations
The largest strength of this study is the extensive phenotyping of a
large number of participants, which made it possible to investigate
several different measures of body fat and subclinical atherosclerosis
and vascular stiffness in relation to borderline Q-waves. There are also
some limitations of this study that need to be considered. In this
study, only 4.6% of participants displayed isolated borderline Q-waves
on the ECG and 1.7% of participants non-isolated borderline Q-waves
[4,6]. Subgroups of participants with increased cardiovascular risk, or
increased waist circumference or VAT were too small and therefore
we did not have enough statistical power to investigate the association
of borderline Q-waves with subclinical atherosclerosis and vascular
stiffness within subgroups. However, the prevalence of borderline
Q-waves observed in this present study is similar to the prevalence in
other population-based studies [4,6]. Also, it should be noted that
coding ECGs according to the Minnesota Coding system is not error-
free. Measurement error is likely to be also present in this study, e.g. if
wrongly measured, a 1.2 code could actually be a 1.1 or 1.3 code.
5. Conclusion
The results of this study show an unfavorable cardiometabolic risk
factor profile in participants with isolated borderline Q-waves that is
even more unfavorable in participants with non-isolated borderline
Q-waves. Furthermore, measures of abdominal adiposity, namely
waist circumference and VAT, were higher in participants with isolated
borderline Q-waves and highest in participants with non-isolated
borderline Q-waves, compared with participants without Q-waves.
Also, non-isolated borderline Q-waves were associated with more
subclinical atherosclerosis and vascular stiffness, results for isolated bor-
derline Q-waves are less clear, despite the less favorable cardiometabolic
risk factor profile.
Borderline Q-waves can be identified on an easily obtainable ECG,
which makes them a possibly useful addition to cardiovascular risk
assessment. The possible added value of borderline Q-waves to current
risk prediction scores for CVD should be further investigated in futurestudies. Furthermore, the prognostic significance of borderline
Q-waves within subgroups of individuals with increased cardiovascular
risk or withmore body fat could be investigated in longitudinal studies.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2018.08.088.
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